# Multicenter Extension Study of Velaglucerase Alfa in Japanese Patients With Gaucher Disease

> **NCT01842841** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 5 (actual)

## Conditions studied

- Gaucher Disease

## Interventions

- **DRUG:** velaglucerase alfa

## Key facts

- **NCT ID:** NCT01842841
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03-13
- **Primary completion:** 2014-10-08
- **Final completion:** 2014-10-08
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2021-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01842841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01842841, "Multicenter Extension Study of Velaglucerase Alfa in Japanese Patients With Gaucher Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01842841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*